TAMPA, FL--(Marketwire - May 27, 2009) - More than 35 million Americans suffer from bladder control problems at some time in their lives. Those suffering from uncontrollable bladder may experience unexpected urine leakage, frequent bathroom use, or have the feeling of not being able to completely empty the bladder. Many people experience a combination of these symptoms. Although it is more common in older adults, and more likely to occur in women than men, it can affect anyone.

For many of these people the last hope is an implantable device known as InterStim® Therapy, which was designed to stimulate communication between the brain and bladder to better control urinary incontinence and retention. Before the device can be implanted, however, doctors must perform a test procedure to determine if it will be effective.

At 4 p.m. on May 20, 2009, this test procedure will be performed live over the Internet from Tampa General Hospital. The test involves placing a thin wire near the tailbone, which is connected to a small stimulator worn on a belt. The stimulator sends mild electrical pulses through the thin wire to the sacral nerves that control the bladder and muscles related to urinary function.

The test is an outpatient procedure typically completed in less than an hour. The patient is placed under a local anesthetic. After the procedure, the patient keeps a journal for a period ranging from five to ten days. If the electrical pulses result in an increase in proper bladder function, the patient may proceed to the surgical implementation procedure.

Raul Ordorica, M.D., Associate Professor, Division of Urology, University of South Florida College of Medicine, will perform the procedure to test the effectiveness of the InterStim® device. Dr. Ordorica has had extensive experience with InterStim® Therapy since it was FDA approved in 1998, and was the first to perform the implant at Tampa General Hospital. The procedure will be narrated by Mark Swierzewski, M.D., Florida Urology Partners.

To view this procedure, log on to www.tgh.org and click on the link on the homepage. If you are unable to view the live broadcast, the procedure will be available on demand at www.tgh.org and www.OR-Live.com for future viewing at your convenience.

About ORLive

ORLive is the world's leading surgical broadcasting company. Working collaboratively with hospitals and device manufacturers, ORLive produces customized, interactive, video programs that demonstrate the latest surgical techniques and product innovations. The ORLive broadcasting network provides an intimate look at over 650 live and on-demand surgeries to a global audience, streaming over 45,000 hours of programming each month. The ORLive network can be found on-line at www.OR-Live.com.